ACMT Position Statement: Medical Toxicology Considerations in the Diagnosis and Treatment of Patients with Concerns About Mold-Related Inhalation Exposures
Jerrold Leikin, Michael G. Holland, Thomas L. Kurt +2 more2025American College of Medical ToxicologyGuideline
Immune/InnateRespiratory/Sinus
Summary
No abstract is available for this paper. It was published in American College of Medical Toxicology in 2025 by Jerrold Leikin and colleagues. Study type: Guideline. CIRS Nexus tags it under Indoor Mold (Stachybotrys, Aspergillus, etc.), Mycotoxins, Water-Damaged Buildings (WDB), Immune/Innate, Respiratory/Sinus.
Part of Mold & water-damaged buildings research, Mycotoxins research · Curated by Lauren Lowenstein, The Biotoxin Lady
Related Papers
- Effects of Mycotoxins on Neuropsychiatric Symptoms and Immune ProcessesClinical Therapeutics · 2018 · 5 shared tags
- The Myth of Mycotoxins and Mold InjuryClinical Reviews in Allergy & Immunology · 2019 · 5 shared tags
- Environmental Mold and Mycotoxin Exposures Elicit Specific Cytokine and Chemokine ResponsesPLoS ONE · 2015 · 5 shared tags
- Cultivation and aerosolization of Stachybotrys chartarum for modeling pulmonary inhalation exposure.Inhalation toxicology · 2019 · 5 shared tags
- 30+ years of knowledge creation: Indoor Air 1991–2021Indoor Air · 2022 · 5 shared tags
- Medizinisch klinische Diagnostik bei Schimmelpilzexposition in Innenräumen – Update 2023 (AWMF-Register-Nr. 161/001)Pneumologie · 2024 · 5 shared tags